<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for North Shields PCN</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>The below reports have been developed to use “z-scores” to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. It is important to remember that
            this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
            method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
            We used the time period from April 2021 to August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the “z-score”, which is a measure
            of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
            for prescribing lower than its peers.</p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=+">survey</a>            or emailing us at
            <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
            feedback.
        </p>
        <h2>Prescribing where North Shields PCN is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0402030R0&amp;denomIds=4.2.3&amp;selectedTab=summary">Asenapine</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>20</td>
      <td>Drugs used for mania and hypomania</td>
      <td>660</td>
      <td>0.03</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>11.04</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0402030R0AAABAB&amp;denomIds=4.2.3&amp;selectedTab=summary" target="_blank">Asenapine 5mg sublingual tablets sugar free : 20</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0601023AI&amp;denomIds=6.1.2&amp;selectedTab=summary">Lixisenatide</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>59</td>
      <td>Other antidiabetic drugs</td>
      <td>2002</td>
      <td>0.03</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>7.31</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0601023AIAAAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Lixisenatide 20micrograms/0.2ml inj 3ml pf dispos dev : 52</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0601023AIAAABAB&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Lixisenatide 10micrograms/0.2ml inj 3ml pf dispos dev : 1</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0601023AIAAACAC&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Lixisenatide 10microg/0.2ml and 20microg/0.2ml inj : 2</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0601023AIBBAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Lyxumia 20micrograms/0.2ml inj 3ml pre-filled pens : 4</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0704020G0&amp;denomIds=7.4.2&amp;selectedTab=summary">Flavoxate hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>82</td>
      <td>Drugs for urinary frequency enuresis and incontinence</td>
      <td>4539</td>
      <td>0.02</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>5.59</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0704020G0AAACAC&amp;denomIds=7.4.2&amp;selectedTab=summary" target="_blank">Flavoxate 200mg tablets : 81</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0704020G0BBABAC&amp;denomIds=7.4.2&amp;selectedTab=summary" target="_blank">Urispas 200 tablets : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0901030N0&amp;denomIds=9.1.3&amp;selectedTab=summary">Methoxy polyethylene glycol-epoetin beta</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Hypoplastic/haemolytic and renal anaemias</td>
      <td>1</td>
      <td>1.00</td>
      <td>0.04</td>
      <td>0.18</td>
      <td>5.47</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0901030N0AAADAD&amp;denomIds=9.1.3&amp;selectedTab=summary" target="_blank">Methoxy polyethylene glycol-epoetin beta 150microg/0.3ml inj : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0408010AI&amp;denomIds=4.8.1&amp;selectedTab=summary">Eslicarbazepine acetate</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>177</td>
      <td>Control of epilepsy</td>
      <td>20981</td>
      <td>0.01</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>5.24</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0408010AIAAAAAA&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Eslicarbazepine 800mg tablets : 106</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0408010AIAAABAB&amp;denomIds=4.8.1&amp;selectedTab=summary" target="_blank">Eslicarbazepine 200mg tablets : 71</a></div></td></tr></tbody></table>

        <h2>Prescribing where North Shields PCN is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0503021C0&amp;denomIds=5.3.2&amp;selectedTab=summary">Aciclovir</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>405</td>
      <td>Herpes simplex and varicella-zoster</td>
      <td>494</td>
      <td>0.82</td>
      <td>0.95</td>
      <td>0.04</td>
      <td>-3.53</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0503021C0AAAAAA&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 200mg/5ml oral suspension sugar free : 5</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0503021C0AAABAB&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 200mg tablets : 113</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0503021C0AAACAC&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 400mg tablets : 181</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0503021C0AAADAD&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 800mg tablets : 77</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0503021C0AAAEAE&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 800mg dispersible tablets : 8</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0503021C0AAAGAG&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 200mg dispersible tablets : 20</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0503021C0AAAHAH&amp;denomIds=5.3.2&amp;selectedTab=summary" target="_blank">Aciclovir 400mg dispersible tablets : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0209000A0&amp;denomIds=2.9&amp;selectedTab=summary">Aspirin</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>9888</td>
      <td>Antiplatelet drugs</td>
      <td>19120</td>
      <td>0.52</td>
      <td>0.65</td>
      <td>0.04</td>
      <td>-3.23</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0209000A0AAABAB&amp;denomIds=2.9&amp;selectedTab=summary" target="_blank">Aspirin 75mg dispersible tablets : 7860</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0209000A0AAAJAJ&amp;denomIds=2.9&amp;selectedTab=summary" target="_blank">Aspirin 75mg tablets : 748</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0209000A0AAAKAK&amp;denomIds=2.9&amp;selectedTab=summary" target="_blank">Aspirin 75mg gastro-resistant tablets : 1280</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=090607000&amp;denomIds=9.6.7&amp;selectedTab=summary">Other multivitamin preparations</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>340</td>
      <td>Multivitamin preparations</td>
      <td>952</td>
      <td>0.36</td>
      <td>0.80</td>
      <td>0.14</td>
      <td>-3.16</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=090607000BBAZAG&amp;denomIds=9.6.7&amp;selectedTab=summary" target="_blank">Dalivit oral drops : 19</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=090607000BBCGAX&amp;denomIds=9.6.7&amp;selectedTab=summary" target="_blank">Ketovite tablets : 14</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=090607000BBEGA1&amp;denomIds=9.6.7&amp;selectedTab=summary" target="_blank">Forceval capsules : 117</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=090607000BBFJBF&amp;denomIds=9.6.7&amp;selectedTab=summary" target="_blank">Abidec Multivitamin drops : 12</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=090607000BBFNBB&amp;denomIds=9.6.7&amp;selectedTab=summary" target="_blank">Boots Multivitamin One A Day tablets : 1</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=090607000BBIKBB&amp;denomIds=9.6.7&amp;selectedTab=summary" target="_blank">Valupak Multivitamin One A Day tablets : 29</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=090607000BBLCA0&amp;denomIds=9.6.7&amp;selectedTab=summary" target="_blank">Forceval Soluble tablets : 14</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=090607000BBLEBB&amp;denomIds=9.6.7&amp;selectedTab=summary" target="_blank">Renavit tablets : 134</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0501050B0&amp;denomIds=5.1.5&amp;selectedTab=summary">Clarithromycin</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>373</td>
      <td>Macrolides</td>
      <td>1850</td>
      <td>0.20</td>
      <td>0.55</td>
      <td>0.12</td>
      <td>-2.91</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAIy0lEQVR4nO2df5BWVRnHPxdQIRRYQ0vTOGLqDGpmZbm5arlK1CXaUYaxHDOhnIEas6biUEPj5DRd0pCpLCUhMc2JMhG8SQFiikaWZRo0lujVmGggXUgLFrLTH8/ZYYHF2R/vfc993/N8Zs7MnfePe7979/2+55znPOc5iXMORVHiYEhoAYqi1A81vKJEhBpeUSJCDa8oEaGGV5SIUMMrSkSo4RUlItTwihIRanhFiQg1vKJERHmGTxLN2VWUijEstAClMTE2fx1wOjABGA+cAIwFWoARwKvAHmArsAXYBPwR+EORpf8IoVmBpLTNM0nicC4p5+ZKPTE2TwADtPl2DnAE8BSwAXgGeA7YBnQCO4GhwKHA0cCxwEnAGcA7/W0fAO4F1hZZ+t86/SnRo4ZXesXYfBxwIdCOGHwbsK67DaaXNjY/xt93KnAmYvwfAb8pslSngiWihlcAMDZ/PfA+xOQXAP8G1vi2rsjSl0t6bgtwMfARYBxwJ/CDIkufL+N5saOGjxQ/B29jby8+GhlmrwEeKLJ0WwBNxwIfAz4OvAAsApYVWdpVby3Niho+Evw8fAIwBZgIvAV4BN+LF1n6bEB5++C1ngvMQEYd9wCLiix9MqiwJkAN38QYmw8FWoEO4EPAS8h8eSXwZJGl/wsor08Ym48CLkXMPxTp9e8qsnR7UGENihq+CTE2PwW4EjHKRmAZsKLI0i1BhQ0SY/PTEONfAjwB3A0sL7K0M6iwBkIN3yQYmw8BJgGfBd6A9IR3Fln6z6DCSsDYfBgy5L8EmAw8zV7z6xr/a6CGb3C80acCc5G18BuBB2NZ3vJ//9lIpH8K8CIyollWZOnTIbVVETV8A2NsPgn4BtLDXRd7UKtHYLID+DCS8fdD4I4iS/8eUltVUMM3IH6OPh8YBVxTZOnjgSVVEmPzE4HLgcuQ1N7bgXuKLN0ZVFhA1PANhLH5GOArSMT9S8BPYxm6DwY/7G8DrkDyDm4DbiqydGtIXSFQwzcAPkj1CWA2cCswP+ZeajD4jMKZyPu8G5gXk/HV8BXH2PxC4AZkp9kcnYvWBmPzkcCnfFsEXB/Dj6gavqIYm08ArkdSXj9XZOljgSU1Jcbmo9k7TfoCsrTXtNMkNXzFMDY/GrgW2cDyZeBnzfwFrArG5qcC3wJ2A58psvQvgSWVghq+InijXwN8FPni3aSbRuqLX9abCnwduAv4WpGlu8Kqqi1q+MAYmxvg80jG2C3Ad4ss3RFUVOQYmx8OXAe8H5hZZOmvAkuqGWr4APiepBWJFp8NLAAWxxA0aiSMzc8CFgK/A77YDDn7avg6Ymx+FJIIMh2p9XYr8JMiS/cEFaYcFGPzQ5D9CTMBCyxt5JiKGr5kfKGJDyI7196BlHJaXGTppqDClH7hs/ZuBrqAWUWWvhBY0oBQw5eAsfkIZOfaNCTDazWwFFilBRsbFz8Vuxz4KrJJ6TtFlr4aVlX/UMPXCGPz4UiQZxpwPlIu6sfAao22Nxd+ajYfOAW4usjS9YEl9Rk1/CAwNj8MKRc1DSnF9CDSk/+y2ZZzlAMxNm8HvomU6p7TCMN8NXw/8XPyi5D91+3AQ4jJf6FR9vjwZcSmI5uZ7kBy818Jq+rgqOH7gLH5WGSdvAM5SKH7EIX7iyz9T0htSjXwtfcsUm77RmBhFUd5avhe8MGZk5HoegdwPLACMfnDuoymHAxj8+OAOUjQ9gZkRaYyMRw1vMcHYtqR4foFyDr5SqRc0hONvPaq1B9j8zcjeyHakU1QS6rQ40dreJ8+2Yr8QyYi1WNWA6uQgxgaPqtKCY+x+QlIHYNJwPeB7xVZ+lIoPdEY3m9OaUOqnbYhlV3XI/PxVZoIo5SJ//59GjlVZxmwIMThH01peF8h5jTgLODdiMFBDkJ82LfndJiu1BtfeGM6MAv4G9Lr31tk6e56PL/hDe/rlY1HzP0u38Yja6O/BR4DHompjJFSfXxg+Dzgk8iocymwBNhQZkfUEIb3L2c0Ei03SCni7nYc8Dxi7G6D/7URjlFSFABj8yORlN1LgbHAcmRF6NFap2LX1PA+8+xwYHgxb/JmM/u+CcBw4LAe7VDfDulx3d1GAWMQc48GWoA3+c+2A5uRU0U3Ij34RmCzmltpFozN34iU2+oAzmDvNPRR4M+DjfT3y/DG5nOBIxEjtvS4HoMc9NcFvAJ0FfMmv93Mvm+t/6wL2IWUD+oC9vjr3ftd/wsx9g7fOhGT79D5thIbfiXpPUgMqhXJ3d+JdHYbkANIthRZuqav9+yv4WchJuxETiLtvt5+wNCjYlF6RWkGjM1bgFN9Owk4psjSy/p8A+dczRtwVRn3bWQtVdFRJS1V0VElLWXrGFKzn559uaqk+w6Eqmipig6ojpaq6IDqaClVR1mGVxSlgqjhFSUiyjL8wpLuOxCqoqUqOqA6WqqiA6qjpVQd5SXeKIpSOXRIrygRMawWN0mS5DwkQWCrc25xkiRXIOuE9zvn1tbiGYPQ8gHgTOAp59yKkFr8ZzcDtznn6lb4sJd3ci2S4PRz51xdz1DrRcu5SFLJeufcQwF1dCCp2iOcc3PrpeMgWmYARwA45xbU8lm16uFbnXMZcBSAc24JUsN7fI3uP2AtyBbY45FMv6BakiS5GCl0GVQH8CIwMoCO3rRMQbLH6p0evf93dhmwCak0XG/2fydDke3bNd/wVSvD7xMISJJkJDADuL1G9x+wFudcJ7IPOcSPz/4BkrciaZLnhNThnPs2cmDi1DrrOEALMMrrmRhYB8Dpzrk/1VkHHKhliHNuDnBirR9Uk6CdH5K0Ium2vweuBp4BVjvnfj3oBwxOy9uQF7feObc8pBbn3ONJkrwX2BVgSN/znZyMTLnWOedW1kvHQbSMQ3ZA7nDOLQqo41ngSufc/HppeA0t5wMJ8LJzrqZRe43SK0pEaJReUSJCDa8oEaGGV5SIUMMrSkSo4RUlItTwihIRanhFiQg1vKJEhBpeUSJCDa8oEaGGV5SI+D+S4o3Nnb8Y+QAAAABJRU5ErkJggg=="></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0501050B0AAAAAA&amp;denomIds=5.1.5&amp;selectedTab=summary" target="_blank">Clarithromycin 250mg tablets : 29</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0501050B0AAABAB&amp;denomIds=5.1.5&amp;selectedTab=summary" target="_blank">Clarithromycin 125mg/5ml oral suspension : 15</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0501050B0AAADAD&amp;denomIds=5.1.5&amp;selectedTab=summary" target="_blank">Clarithromycin 500mg tablets : 313</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0501050B0AAAEAE&amp;denomIds=5.1.5&amp;selectedTab=summary" target="_blank">Clarithromycin 500mg modified-release tablets : 1</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0501050B0AAAHAH&amp;denomIds=5.1.5&amp;selectedTab=summary" target="_blank">Clarithromycin 250mg/5ml oral suspension : 15</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0407010F0&amp;denomIds=4.7.1&amp;selectedTab=summary">Co-codamol (Codeine phosphate/paracetamol)</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>2456</td>
      <td>Non-opioid analgesics and compound preparations</td>
      <td>19088</td>
      <td>0.13</td>
      <td>0.44</td>
      <td>0.12</td>
      <td>-2.55</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0407010F0AAAAAA&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Co-codamol 8mg/500mg tablets : 972</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0407010F0AAABAB&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Co-codamol 8mg/500mg capsules : 45</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0407010F0AAACAC&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Co-codamol 8mg/500mg effervescent tablets : 203</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0407010F0AAADAD&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Co-codamol 30mg/500mg capsules : 266</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0407010F0AAAFAF&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Co-codamol 30mg/500mg effervescent tablets : 85</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0407010F0AAAHAH&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Co-codamol 30mg/500mg tablets : 652</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0407010F0AAAKAK&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Co-codamol 15mg/500mg tablets : 132</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0407010F0AAAVAV&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Co-codamol 15mg/500mg capsules : 33</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0407010F0BEAAAD&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Tylex 30mg/500mg capsules : 7</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0407010F0BGAAAF&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Solpadol 30mg/500mg effervescent tablets : 10</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0407010F0BGABAH&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Solpadol 30mg/500mg caplets : 29</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0407010F0BHAAAH&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Kapake 30mg/500mg tablets : 15</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0407010F0BSAAAH&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Zapain 30mg/500mg tablets : 1</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U91110&amp;numIds=0407010F0BXAAAA&amp;denomIds=4.7.1&amp;selectedTab=summary" target="_blank">Migraleve Yellow tablets : 6</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>